What’s Next? Five Things To Look Out For In April
Japan Prepares Further Round Of Price Revisions; US Combigan Patents To Lapse
In the month ahead, Japanese firms are set to be hit with further price cuts to their generics, while Eagle Pharmaceuticals will throw off the restraints for its Pemfexy (pemetrexed) 505(b)(2) version of Eli Lilly’s Alimta.
